PDS Biotechnology (PDSB) EV/Sales: History & Chart

PDS Biotechnology Corporation(PDSB)

Biotechnology · Princeton, NJ

$0.21-0.01 (-3.21%)

At close: Aug 28, 2026, 4:00 PM ET

About PDS Biotechnology Corporation

PDS Biotechnology Corporation is a clinical-stage biopharmaceutical firm dedicated to advancing innovative, multi-functional immunotherapies to combat cancer. Its primary drug candidate, PDS0101 (HPV16), is currently undergoing Phase II clinical trials, positioned as an initial treatment option for recurrent or metastatic head and neck cancer, human papillomavirus (HPV)-associated malignancies, and cervical cancer. The company's developmental pipeline further includes several preclinical product candidates. These comprise PDS0102, utilizing T-cell receptor gamma alternate reading frame protein (TARP) for prostate and breast cancers; PDS0103 (MUC-1) targeting ovarian, colorectal, lung, and breast cancers; and PDS0104, which incorporates Tyrosinase-related protein 2 for the treatment of melanoma. Beyond oncology, PDS Biotechnology is also engaged in developing treatments for infectious diseases, with candidates such as PDS0201 for tuberculosis, PDS0202 as an investigational influenza vaccine, and PDS0203, a vaccine aimed at preventing COVID-19. The company has established strategic partnerships and licensing agreements with notable entities including the National Institutes of Health, Merck Eprova AG, The U.S. Department of Health and Human Services, and MSD International GmbH. PDS Biotechnology Corporation was founded in 2005 and is headquartered in Florham Park, New Jersey.

Princeton, NJ

21 employees

www.pdsbiotech.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Frank K. Bedu-Addo

View full financials

NAME	MARKET CAP	EV/SALES RATIO	TTM	3Y	5Y
PDS Biotechnology Corporation (PDSB)	$11.79M	N/A	N/A	N/A	N/A
Shoulder Innovations, Inc. (SI)vs ›	$438.82M	7.15x	6.57x	6.68x	6.68x
NRC Health (NRC)vs ›	$492.43M	4.05x	3.34x	4.17x	5.25x
Teladoc Health, Inc. (TDOC)vs ›	$1.18B	0.58x	0.61x	0.84x	2.32x
DENTSPLY SIRONA Inc. (XRAY)vs ›	$2.23B	1.18x	1.24x	1.62x	2.04x
TransMedics Group, Inc. (TMDX)vs ›	$3.06B	5.98x	7.69x	10.26x	15.28x
Doximity, Inc. (DOCS)vs ›	$5.00B	7.39x	11.95x	14.56x	19.86x
Merit Medical Systems, Inc. (MMSI)vs ›	$5.40B	3.67x	3.42x	3.94x	3.86x
Hims & Hers Health, Inc. (HIMS)vs ›	$6.43B	2.96x	3.98x	4.25x	4.07x
Chemed Corporation (CHE)vs ›	$6.84B	2.82x	2.52x	3.24x	3.40x

NAME

MARKET CAP

EV/SALES RATIO

TTM

PDS Biotechnology Corporation (PDSB)

$11.79M

N/A

Shoulder Innovations, Inc. (SI)vs ›

$438.82M

7.15x

6.57x

6.68x

NRC Health (NRC)vs ›

$492.43M

4.05x

3.34x

4.17x

5.25x

Teladoc Health, Inc. (TDOC)vs ›

$1.18B

0.58x

0.61x

0.84x

2.32x

DENTSPLY SIRONA Inc. (XRAY)vs ›

$2.23B

1.18x

1.24x

1.62x

2.04x

TransMedics Group, Inc. (TMDX)vs ›

$3.06B

5.98x

7.69x

10.26x

15.28x

Doximity, Inc. (DOCS)vs ›

$5.00B

7.39x

11.95x

14.56x

19.86x

Merit Medical Systems, Inc. (MMSI)vs ›

$5.40B

3.67x

3.42x

3.94x

3.86x

Hims & Hers Health, Inc. (HIMS)vs ›

$6.43B

2.96x

3.98x

4.25x

4.07x

Chemed Corporation (CHE)vs ›

$6.84B

2.82x

2.52x

3.24x

3.40x

EV/Sales Ratio: N/A

PDSB EV/Sales Ratio Metrics

PDSB Competitors' EV/Sales Ratio

Understanding EV/Sales

EV/Sales Ratio Formula & Definition

Related Metrics